Erizepine, with the CAS number 96645-87-3, is a chemical compound that belongs to the class of medications known as calcium channel blockers. It is primarily used in the treatment of hypertension and certain types of angina. The compound works by inhibiting the influx of calcium ions through voltage-gated calcium channels in cardiac and smooth muscle cells, leading to vasodilation and a reduction in blood pressure. Erizepine is characterized by its ability to selectively target specific calcium channels, which contributes to its therapeutic effects while minimizing side effects. The compound typically exhibits a moderate to high lipophilicity, influencing its absorption and distribution in the body. Additionally, it may undergo hepatic metabolism, and its pharmacokinetics can be affected by factors such as age, liver function, and concurrent medications. As with any medication, potential side effects may include dizziness, headache, and gastrointestinal disturbances. It is essential for patients to consult healthcare professionals for appropriate dosing and monitoring while using this medication.

Erizepine

96645-87-3:  1,2,3,4,5,10-Hexahydro-3,10-dimethylazepino(4,5-d)dibenz(b,f)azepine,  UNII-7N7IQB45VO,  1,2,3,4,5,10-Hexahydro-3,10-dimethylazepino(4,5-d)dibenz(b,f)azepine.,  3,10-dimethyl-1,2,3,4,5,10-hexahydroazepino[4,5-d]dibenzo[b,f]azepine, Erizepine [INN]

Erizepine, an octopamine receptor 3 (OAR3) antagonist, exhibits a Ki value of 474 nM. This compound is utilized in insect research.

CAS 96645-87-3: Erizepine

Erizepine

Ref: TM-T201442